Loading...
•
Sep 30, 2023
DexCom Q3 2023 Earnings Report
Reported solid financial results and advanced global access to Dexcom CGM.
Key Takeaways
Dexcom's Q3 2023 revenue grew by 27% year-over-year to $975.0 million. The company raised its full-year revenue and margin guidance and announced a $500 million share repurchase program.
Revenue grew 27% versus the same quarter of the prior year to $975.0 million.
U.S. revenue growth of 24% and international revenue growth of 33%.
GAAP operating income of $205.5 million or 21.1% of revenue.
Secured reimbursement for Dexcom ONE in France.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company is increasing fiscal year 2023 guidance for Revenue, Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin.
Positive Outlook
- Revenue of approximately $3.575 - 3.600 billion (23-24% growth)
- Non-GAAP Gross Profit Margin of approximately 64%
- Non-GAAP Operating Margin of approximately 19%
- Adjusted EBITDA Margin of approximately 28%
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...